Camptothecin (CPT) is a natural alkaloid with broad antitumor activity. It was originally discovered from the bark of Camptotheca acuminata in the family Camptotheca, and has subsequently been obtained from other plants, microorganisms, and synthetically. This article will describe all the uses of Camptothecin, including the treatment of various cancers, DNA topoisomerase inhibitors, and other biological applications.
1. Anticancer therapeutic agent:
Camptothecin is a potent antineoplastic agent that has received widespread attention because it prevents the unblocking of the helical structure of DNA during replication and transcription by activating DNA topoisomerase I. It comes in a variety of dosage forms, including oral, intravenous, and drug delivery pumps. Camptothecin and its derivative compounds have been widely used in single-drug and combined chemotherapy regimens to treat cancers, such as ovarian cancer, colorectal cancer, liver cancer, and non-small cell lung cancer and other malignant tumors.
2. DNA Topoisomerase Inhibitor (DNA Topoisomerase Inhibitor):
Camptothecin can selectively inhibit the activity of DNA topoisomerase I (TopoI), which is responsible for relaxing the supercoil of DNA double strands and plays a key role in the process of DNA replication and transcription. Camptothecin binds to the interaction site between Topo I enzyme and DNA to form a complex, which can lock the Topo I enzyme-DNA complex and cause DNA single-strand breaks, thereby killing tumor cells. The analogues of camptothecin inhibited Topo II less significantly. Therefore, Camptothecin can be a Topo I-specific antitumor drug.
3. Treatment of Williams Syndrome:
Williams syndrome is a common human genetic disorder caused by deletion of the long arm of chromosome 7. Symptoms include mental retardation, facial deformities, scream response, cardiovascular disease, etc. Recent studies have shown that Camptothecin can suppress chromosome deletion symptoms including Williams syndrome by reducing and restoring the activity of the four-dimensional transcription factor (EZH2). This research opens up new opportunities for treating Williams syndrome.
4. Research on supercyclization:
Hyperhybridin is a new type of compound, which is composed of a cyclic peptide and a link between two CPT molecules, and is currently a research hotspot. Unlike common peptide synthesis methods, the construction of hyperhybridins requires "burying" two compounds in a cyclic peptide. Therefore, the synthesis of hyperhybridins requires the development of new compound synthesis techniques, and Camptothecin and its active derivatives are the main candidates for this technique.
5. Use of Camptothecin tracer reagent:
Camptothecin derivatives are also widely used in biological research as Camptothecin tracer reagents. These camptothecin derivatives can interact with TEL(P)-binding proteins such as TRF1 or TRF2, or interact with Fe3+, Cu2+ plasmonic systems. This interaction can provide a high degree of selectivity for the target protein, further providing a relevant method for biophysical chemistry research.
In summary, Camptothecin and its compounds have a wide range of applications in biomedical research. In cancer treatment, Camptothecin is one of the most effective anti-tumor agents and can be combined with many drugs to enhance the therapeutic effect. In DNA topoisomerase research, Camptothecin has not only been used to treat cancer, but also opened up new avenues for research in this field. In other fields, such as Williams syndrome, hyperhybridine synthesis and biophysical chemistry research, the application of Camptothecin and its derivatives has also made breakthroughs.
Camptothecin (CPT), a natural plant alkaloid mainly found in Camptothecaceae plants in southern China, has a wide range of antitumor activities. From the chemical structure point of view, CPT molecule is a condensed ring polycyclic aromatic compound rich in nitrogen, aromatic ring and pyrrole ring. Its alkaloid not only has broad-spectrum anticancer activity, but also has selective toxicity to cancer. The drug is highly safe and has multiple mechanisms of action.
The pharmacodynamic mechanism of CPT drugs in the body is mainly related to its combination with DNA. CPT can specifically react with acid groups in DNA, and inhibit the activity of DNA topoisomerase I (Topo I) during the reaction process. , causing DNA to suffer single-strand breaks and making it difficult to replicate, thereby inhibiting cell proliferation and division, and inducing apoptosis of target cancer cells. However, with the widespread use of drugs, the problems of drug resistance and side effects of patients have also surfaced. Therefore, it has become a direction for researchers to seek powerful metal complexes as alternatives.
CPT is a class of drugs widely used in the treatment of tumors, namely topoisomerase inhibitors. It can inhibit the activity of DNA topoisomerase I, thereby changing the topological structure of DNA; because its structure is similar to IR receptors, it is activated by IR in vivo, and it can achieve better therapeutic effects through synergistic use with other drugs. CPT drugs have brought more hope to cancer patients, but with it come side effects and the emergence of drug resistance. In response to these problems, many CPT derivatives based on metal complexes have emerged in recent years. These derivatives can not only inherit the therapeutic properties of CPT, but also reduce side effects and drug resistance, so they have become one of the hot spots in the research of CPT derivatives. . CPT is a very promising anticancer drug and has a wide range of applications in tumor therapy.